• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

预测恶性输尿管梗阻患者内镜下输尿管支架置入失败的因素:系统评价和荟萃分析。

Predictors for failure of endoscopic ureteric stenting in patients with malignant ureteric obstruction: systematic review and meta-analysis.

机构信息

Department of Surgery/Urology, School of Medicine, Universidad del Valle, Cali, Colombia.

UROGIV Research Group, Universidad del Valle, Cali, Colombia.

出版信息

BJU Int. 2021 Mar;127(3):292-299. doi: 10.1111/bju.15237. Epub 2020 Sep 25.

DOI:10.1111/bju.15237
PMID:32916038
Abstract

OBJECTIVE

To determine the factors for failure of endoscopic ureteric stenting in patients with malignant ureteric obstruction.

METHODS

We performed a search strategy in the Medical Literature Analysis and Retrieval System Online (MEDLINE), the Excerpta Medica dataBASE (EMBASE), the Literatura Latino-Americana e do Caribe em Ciências da Saúde database (LILACS), and the Cochrane Central Register of Controlled Trials (CENTRAL) databases. We included patients with malignant ureteric obstruction, who had a JJ catheter insertion. The studies reported the percentage of failure and risk factors, e.g. bladder invasion or deformity of the trigone, hydronephrosis, renal failure, previous radiotherapy, age, obstruction aetiology, and patient's health status. We performed a meta-analysis using R software ('meta' and 'metafor' libraries).

RESULTS

We included nine studies that met the inclusion criteria, with 761 patients and an average age of 60.5 years. The studies assessed the time to failure during the first 30 days. The reported failure rate was 32% (95% confidence interval [CI] 21-45%; I = 88%). Regarding risk factors for failure, bladder invasion or deformity of the trigone had a hazard ratio (HR) of 4.8 (95% CI 1.28-8.5; I = 97.4%); severe hydronephrosis had a HR of 3.92 (95% CI 0.32-7.52; I = 93.9%); and age <65 years had a HR of 0.93 (95% CI 0.8-0.9; I = 0%).

CONCLUSIONS

We found a high probability of failure for endoscopic urinary decompression in patients with malignant ureteric obstruction. Factors such as bladder invasion or deformity of the trigone and age >65 years had an increased risk of failure.

摘要

目的

确定恶性输尿管梗阻患者内镜下输尿管支架置入失败的相关因素。

方法

我们在 Medline(医学文献分析和检索系统在线版)、Excerpta Medica dataBASE(EMBASE)、Literatura Latino-Americana e do Caribe em Ciências da Saúde 数据库(LILACS)和 Cochrane 对照试验中心注册库(CENTRAL)中进行了检索策略。我们纳入了接受 JJ 导管插入术的恶性输尿管梗阻患者。这些研究报告了失败率和危险因素,例如膀胱侵犯或三角区变形、肾积水、肾功能衰竭、先前的放疗、年龄、梗阻病因和患者的健康状况。我们使用 R 软件(“meta”和“metafor”库)进行了 meta 分析。

结果

我们纳入了 9 项符合纳入标准的研究,共 761 名患者,平均年龄为 60.5 岁。这些研究评估了第 1 个 30 天内的失败时间。报告的失败率为 32%(95%置信区间 [CI] 21-45%;I = 88%)。关于失败的危险因素,膀胱侵犯或三角区变形的危险比(HR)为 4.8(95% CI 1.28-8.5;I = 97.4%);严重肾积水的 HR 为 3.92(95% CI 0.32-7.52;I = 93.9%);年龄 <65 岁的 HR 为 0.93(95% CI 0.8-0.9;I = 0%)。

结论

我们发现恶性输尿管梗阻患者内镜下尿路减压术失败的可能性较高。膀胱侵犯或三角区变形和年龄 >65 岁等因素增加了失败的风险。

相似文献

1
Predictors for failure of endoscopic ureteric stenting in patients with malignant ureteric obstruction: systematic review and meta-analysis.预测恶性输尿管梗阻患者内镜下输尿管支架置入失败的因素:系统评价和荟萃分析。
BJU Int. 2021 Mar;127(3):292-299. doi: 10.1111/bju.15237. Epub 2020 Sep 25.
2
Ureteric stents vs percutaneous nephrostomy for initial urinary drainage in children with obstructive anuria and acute renal failure due to ureteric calculi: a prospective, randomised study.输尿管支架与经皮肾造瘘术用于输尿管结石所致梗阻性无尿和急性肾衰竭患儿的初始尿液引流:一项前瞻性随机研究
BJU Int. 2015 Mar;115(3):473-9. doi: 10.1111/bju.12768. Epub 2014 Oct 20.
3
The outcome with ureteric stents for managing non-urological malignant ureteric obstruction.输尿管支架治疗非泌尿系统恶性输尿管梗阻的疗效
BJU Int. 2007 Dec;100(6):1288-91. doi: 10.1111/j.1464-410X.2007.07172.x. Epub 2007 Sep 10.
4
Outcome of retrograde ureteric stenting as a urinary drainage procedure in ureteric obstruction related to malignant lesions.逆行输尿管支架置入术作为与恶性病变相关的输尿管梗阻的尿液引流手术的疗效
Ceylon Med J. 2014 Dec;59(4):124-7. doi: 10.4038/cmj.v59i4.7864.
5
Extra-Anatomic Stents in Ureteric Obstruction: Our Experience.解剖外支架在输尿管梗阻中的应用:我们的经验。
J Endourol. 2019 Mar;33(3):242-247. doi: 10.1089/end.2018.0610. Epub 2019 Feb 1.
6
Outcomes of stenting after uncomplicated ureteroscopy: systematic review and meta-analysis.单纯输尿管镜检查术后支架置入的结果:系统评价与荟萃分析。
BMJ. 2007 Mar 17;334(7593):572. doi: 10.1136/bmj.39119.595081.55. Epub 2007 Feb 20.
7
[Clinical evaluation of ureteral stenting for managing extrinsic ureteral obstruction due to gynecological and gastrointestinal cancer].[输尿管支架置入术治疗妇科及胃肠道癌症所致输尿管外源性梗阻的临床评估]
Hinyokika Kiyo. 2014 Jan;60(1):13-6.
8
The role of percutaneous nephrostomy in malignant ureteric obstruction.经皮肾造瘘术在恶性输尿管梗阻中的作用。
Ann R Coll Surg Engl. 2005 Jan;87(1):21-4. doi: 10.1308/1478708051432.
9
The resonance® metallic ureteric stent in the treatment of chronic ureteric obstruction: a safety and efficacy analysis from a contemporary clinical series.共振®金属输尿管支架治疗慢性输尿管梗阻:来自当代临床系列的安全性和有效性分析。
BMC Urol. 2017 Mar 10;17(1):16. doi: 10.1186/s12894-017-0204-8.
10
The resonance® metallic ureteral stent in the treatment of malignant ureteral obstruction: a prospective observational study.《谐振®金属输尿管支架治疗恶性输尿管梗阻:前瞻性观察研究》。
BMC Urol. 2019 Dec 27;19(1):137. doi: 10.1186/s12894-019-0569-y.

引用本文的文献

1
Outcomes of nephrostomy and double J stent in malignant ureteral obstruction in the Palestinian practice.在巴勒斯坦的实践中,经皮肾造瘘术和双 J 支架治疗恶性输尿管梗阻的结果。
BMC Urol. 2024 Nov 7;24(1):245. doi: 10.1186/s12894-024-01640-3.
2
Malignant ureteral obstruction: comparison of metallic, 8 French and 6 French ureteric stents after failure of initial ureteric stent.恶性输尿管梗阻:初次输尿管支架置入失败后,8Fr 与 6Fr 金属及塑料输尿管支架的比较。
World J Urol. 2024 Feb 22;42(1):92. doi: 10.1007/s00345-024-04803-x.
3
Can preoperative ureteral stents reduce the incidence of ureteral stricture after radiotherapy in patients with cervical cancer?
术前输尿管支架置入能否降低宫颈癌放疗后输尿管狭窄的发生率?
BMC Urol. 2022 Jul 18;22(1):106. doi: 10.1186/s12894-022-01029-0.